Nanosphere Files for $100 Million IPO
Illinois-based Nanosphere is a medical device company focused on nano-enhanced solutions for medicine, including molecular diagnostic tests, and tests for cancer, herpes viral infection, and cystic fibrosis gene mutation. This is a promising development for the nanotechnology marketplace, since NanoDynamics announced it planned to postpone its IPO plans in early August. Nanosphere plans to use the offering to finance R&D, product manufacturing, marketing, and general budget needs. Underwriters for the IPO include Credit Suisse, Piper Jaffray, Leerink Swann & Co. and Allen & Co.